Advertisement

Bladder cancer to patients younger than 30 years: a retrospective study and review of the literature

Abstract

Objectives

The aim of this report was to study the specific characteristics of bladder cancer in patients younger than 30 years.

Materials and methods

Five patients with a mean age of 24 ± 2.83 years were included in the study. All patients had painless macroscopic hematuria as the first symptom. Three patients had pTa as a first diagnosis, one had pT1 and one pT2. All the patients had smoking as a risk factor and at least one additional possible risk factor.

Results

One patient with pTa had an aggressive course and after multiple recurrences was diagnosed with pT2 and refused to be submitted to radical cystectomy and died from the disease even though he received a multimodality treatment. The other two patients with the pTa diagnosis had no recurrence after the first TUR-BT and the patient with the pT1 diagnosis after one recurrence with a pTa histology is free of recurrence for the last 2 years. The patient diagnosed with pT2 was submitted to a radical cystectomy and an s-pouch diversion with a preservation of the genital system in order to have the ability of a future motherhood with the acceptance of course risks.

Conclusions

Young patients with bladder cancer is a difficult group of patients and show more reluctance to comply to the necessary strict follow-up of the repeated urinary cytology examinations, cystoscopies and CT pyelographies. Herein, we report a retrospective study of five patients younger than 30 years with bladder cancer.

Urologia 2017; 84(4): 231 - 235

Article Type: ORIGINAL RESEARCH ARTICLE

DOI:10.5301/uj.5000264

Authors

Ioannis Katafigiotis, Stavros Sfoungaristos, Alberto Martini, Konstantinos Stravodimos, Ioannis Anastasiou, Ioannis Mykoniatis, Mordechai Duvdevani, Constantinos Constantinides

Article History

Disclosures

Financial support: This study has not received any funding or support.
Conflict of interest: The authors have no conflicts of interest.

This article is available as full text PDF.

  • If you are a Subscriber, please log in now.

  • Article price: Eur 36,00
  • You will be granted access to the article for 72 hours and you will be able to download any format (PDF or ePUB). The article will be available in your login area under "My PayPerView". You will need to register a new account (unless you already own an account with this journal), and you will be guided through our online shop. Online purchases are paid by Credit Card through PayPal.
  • If you are not a Subscriber you may:
  • Subscribe to this journal
  • Unlimited access to all our archives, 24 hour a day, every day of the week.

Authors

Affiliations

  • 1st University Urology Clinic, Laiko Hospital, Athens - Greece
  • Hebrew Hadassah University Medical Center, Jerusalem - Israel
  • Unit of Urology, Urological Research Institute, Division of Experimental Oncology, Vita-Salute San Raffaele University, IRCCS San Raffaele Scientific Institute, Milan - Italy
  • 1st Department of Urology, G. Gennimatas Hospital, Aristotle University, Thessaloniki - Greece

Article usage statistics

The blue line displays unique views in the time frame indicated.
The yellow line displays unique downloads.
Views and downloads are counted only once per session.

No supplementary material is available for this article.